Alkermes plc. Long-Term Debt
Alkermes plc. (ALKS) had Long-Term Debt of $1.48 billion as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2026-07-28
- 2026-06-30: Long-term Debt, Excluding Current Maturities $1.48B.
- 2026-03-31: Long-term Debt, Excluding Current Maturities $1.48B.
- 2025-12-31: Long-term Debt, Excluding Current Maturities $0.00.
- 2024-09-30: Long-term Debt, Excluding Current Maturities $285.82M.
| Period end | Long-term Debt, Excluding Current Maturities | Long-term Debt, Excluding Current Maturities as first filed |
|---|---|---|
| 2026-06-30 | $1.48B 10-Q · filed 2026-07-28 | |
| 2026-03-31 | $1.48B 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $0.00 10-Q · filed 2026-07-28 | |
| 2024-09-30 | $285.82M 10-Q · filed 2024-10-24 | |
| 2024-06-30 | $286.46M 10-Q · filed 2024-07-24 | |
| 2024-03-31 | $287.10M 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $287.73M 10-K · filed 2025-02-12 | |
| 2023-09-30 | $288.37M 10-Q · filed 2023-10-25 | |
| 2023-06-30 | $289.00M 10-Q · filed 2023-07-26 | |
| 2023-03-31 | $289.63M 10-Q · filed 2023-04-26 | |
| 2022-12-31 | $290.27M 10-K · filed 2024-02-21 | |
| 2022-09-30 | $290.90M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $291.54M 10-Q · filed 2022-07-27 | |
| 2022-03-31 | $292.17M 10-Q · filed 2022-04-27 | |
| 2021-12-31 | $292.80M 10-K · filed 2023-02-16 | |
| 2021-09-30 | $293.44M 10-Q · filed 2021-10-27 | |
| 2021-06-30 | $294.07M 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $294.70M 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $272.12M 10-K · filed 2022-02-16 | |
| 2020-09-30 | $272.66M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $273.21M 10-Q · filed 2020-07-29 | |
| 2020-03-31 | $273.75M 10-Q · filed 2020-04-29 | |
| 2019-12-31 | $274.30M 10-K · filed 2021-02-11 | |
| 2019-09-30 | $274.84M 10-Q · filed 2019-10-23 | |
| 2019-06-30 | $275.38M 10-Q · filed 2019-07-25 | |
| 2019-03-31 | $275.92M 10-Q · filed 2019-04-25 | |
| 2018-12-31 | $276.46M 10-K · filed 2020-02-13 | |
| 2018-09-30 | $277.01M 10-Q · filed 2018-10-23 | |
| 2018-06-30 | $277.55M 10-Q · filed 2018-07-26 | |
| 2018-03-31 | $278.09M 10-Q · filed 2018-04-26 | |
| 2017-12-31 | $278.44M 10-K · filed 2019-02-15 | |
| 2017-09-30 | $278.99M 10-Q · filed 2017-10-26 | |
| 2017-06-30 | $279.55M 10-Q · filed 2017-07-27 | |
| 2017-03-31 | $280.11M 10-Q · filed 2017-04-27 | |
| 2016-12-31 | $280.67M 10-K · filed 2018-02-16 | |
| 2016-09-30 | $282.58M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $283.12M 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $283.66M 10-Q · filed 2016-04-28 | |
| 2015-12-31 | $284.21M 10-K · filed 2017-02-17 | |
| 2015-09-30 | $286.51M 10-Q · filed 2015-10-29 | |
| 2015-06-30 | $348.06M 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $349.64M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $349.01M 10-K · filed 2016-02-25 | $351.22M 10-K · filed 2015-02-24 |
| 2014-09-30 | $352.80M 10-Q · filed 2014-10-29 | |
| 2014-06-30 | $354.38M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $355.96M 10-Q · filed 2014-04-30 | |
| 2013-12-31 | $357.54M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $359.12M 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $360.69M 10-Q · filed 2013-07-25 | |
| 2013-03-31 | $362.26M 10-KT · filed 2014-02-27 | |
| 2012-12-31 | $362.35M 10-Q · filed 2013-01-31 | |
| 2012-09-30 | $363.85M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $441.08M 10-Q · filed 2012-07-26 | |
| 2012-03-31 | $441.36M 10-K · filed 2013-05-23 | |
| 2011-12-31 | $441.67M 10-Q · filed 2012-02-02 | |
| 2011-09-30 | $441.86M 10-Q · filed 2011-11-03 | |
| 2011-03-31 | $0.00 10-Q · filed 2011-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |